William V Williams - 23 Dec 2022 Form 4 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Reporting relationship: President, CEO, Director
Issuer ticker: BCTX
Reported as of: 23 Dec 2022
Net transaction value: +$4,908
SEC form: 4
Accepted by SEC: 28 Dec 2022, 14:22:52 UTC
Prior SEC filing: 01 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ William V. Williams

Filing notes and source

Key filing fact

William V Williams filed Form 4 for BriaCell Therapeutics Corp. (BCTX) on 28 Dec 2022.

Key facts

This page summarizes William V Williams's Form 4 filing for BriaCell Therapeutics Corp. (BCTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Dec 2022, 14:22.

Change

Previous filing in this sequence was filed on 01 Aug 2022.
Current net transaction value: +$4,908.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCTX transaction Derivative

Warrant

Purchase

Transaction value: $4,908
Shares: +2,530
Change %: +9.3%
Price: $1.94
Shares after: 29,802
Date: 23 Dec 2022
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 2,530
Exercise price: $5.31
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 8 is a weighted average price. These Warrants were purchased in multiple transactions at prices ranging from $1.97 to $2.00 per Warrant, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Warrants purchased at each separate price within the ranges set forth herein.